These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 23730993)
21. A meta-analysis of randomized controlled trials of azilsartan therapy for blood pressure reduction. Takagi H; Mizuno Y; Niwa M; Goto SN; Umemoto T Hypertens Res; 2014 May; 37(5):432-7. PubMed ID: 24108238 [TBL] [Abstract][Full Text] [Related]
22. Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice. Hou PY; Mi C; He Y; Zhang J; Wang SQ; Yu F; Anderson S; Zhang YW; Wu XH Fitoterapia; 2015 Sep; 105():43-8. PubMed ID: 26051087 [TBL] [Abstract][Full Text] [Related]
23. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review. Hu AM; Brown JN Clin Rheumatol; 2020 Nov; 39(11):3287-3294. PubMed ID: 32418037 [TBL] [Abstract][Full Text] [Related]
24. Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis. Liu G; Zheng XX; Xu YL; Lu J; Hui RT; Huang XH J Hum Hypertens; 2015 Mar; 29(3):159-66. PubMed ID: 25078487 [TBL] [Abstract][Full Text] [Related]
25. The Effects of LCZ696 in Patients With Hypertension Compared With Angiotensin Receptor Blockers: A Meta-Analysis of Randomized Controlled Trials. Zhao Y; Yu H; Zhao X; Ma R; Li N; Yu J J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):447-457. PubMed ID: 28793821 [TBL] [Abstract][Full Text] [Related]
26. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. He FJ; Li J; Macgregor GA BMJ; 2013 Apr; 346():f1325. PubMed ID: 23558162 [TBL] [Abstract][Full Text] [Related]
27. Effect of Home Medication Titration on Blood Pressure Control in Patients With Hypertension: A Meta-Analysis of Randomized Controlled Trials. Chen TY; Kao CW; Cheng SM; Chang YC Med Care; 2019 Mar; 57(3):230-236. PubMed ID: 30762831 [TBL] [Abstract][Full Text] [Related]
28. Exercise Reduces Ambulatory Blood Pressure in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Saco-Ledo G; Valenzuela PL; Ruiz-Hurtado G; Ruilope LM; Lucia A J Am Heart Assoc; 2020 Dec; 9(24):e018487. PubMed ID: 33280503 [TBL] [Abstract][Full Text] [Related]
29. Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study. Alghamdi YS; Soliman MM; Nassan MA BMC Pharmacol Toxicol; 2020 Feb; 21(1):10. PubMed ID: 32041665 [TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure. Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T; Hypertens Res; 2013 Nov; 36(11):959-66. PubMed ID: 23945962 [TBL] [Abstract][Full Text] [Related]
31. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265 [TBL] [Abstract][Full Text] [Related]
32. Class effect of xanthine oxidase inhibitors on flow-mediated dilatation in hypertensive patients: A randomized controlled trial. Hoshide S; Kabutoya T; Ueno H; Kario K J Clin Hypertens (Greenwich); 2020 Mar; 22(3):451-456. PubMed ID: 31873985 [TBL] [Abstract][Full Text] [Related]
33. Long-term effects of weight-reducing drugs in people with hypertension. Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640 [TBL] [Abstract][Full Text] [Related]
34. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Khalesi S; Sun J; Buys N; Jayasinghe R Hypertension; 2014 Oct; 64(4):897-903. PubMed ID: 25047574 [TBL] [Abstract][Full Text] [Related]
36. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. Bangalore S; Toklu B; Gianos E; Schwartzbard A; Weintraub H; Ogedegbe G; Messerli FH Am J Med; 2017 Jun; 130(6):707-719.e8. PubMed ID: 28109971 [TBL] [Abstract][Full Text] [Related]
37. A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout. Faruque LI; Ehteshami-Afshar A; Wiebe N; Tjosvold L; Homik J; Tonelli M Semin Arthritis Rheum; 2013 Dec; 43(3):367-75. PubMed ID: 24326033 [TBL] [Abstract][Full Text] [Related]
38. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838 [TBL] [Abstract][Full Text] [Related]
39. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Zhang X; Li Y; Del Gobbo LC; Rosanoff A; Wang J; Zhang W; Song Y Hypertension; 2016 Aug; 68(2):324-33. PubMed ID: 27402922 [TBL] [Abstract][Full Text] [Related]
40. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Castrejon I; Toledano E; Rosario MP; Loza E; Pérez-Ruiz F; Carmona L Rheumatol Int; 2015 Jul; 35(7):1127-37. PubMed ID: 25519877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]